Skip to Main Content

Author Details

Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
2007
289
46
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35211781Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis.J Cancer Res Clin Oncol2023
38024240Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma.Neurooncol Adv2023
37627318Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis.Biomolecules2023
37907716Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.J Neurooncol2023
38001610Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma.Cancers (Basel)2023
37791376JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.JHEP Rep2023
37248468A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.Mol Cancer2023
37047153Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide.Int J Mol Sci2023
36982604Extracellular Matrix Changes in Subcellular Brain Fractions and Cerebrospinal Fluid of Alzheimer's Disease Patients.Int J Mol Sci2023
37114125Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.Front Oncol2023
37409376Cd44v6 acts as a directional responding factor in the process of transcoelomic metastasis from gastric carcinoma to Krukenberg tumor.Expert Rev Mol Diagn2023
36974813Expression of Eukaryotic Translation Initiation Factors in the Urothelial Carcinoma of the Bladder.Anticancer Res2023
37301535The Oncogenic Protein Kinase/ATPase RIOK1 Is Up-Regulated via the c-myc/E2F Transcription Factor Axis in Prostate Cancer.Am J Pathol2023
36592477Analysis of Cytological Misdiagnosis and Oversight of Adenoid Cystic Carcinoma of Salivary Gland.Cancer Control2023
36653904Genetic alterations of GI-NECs involving three main signaling pathways.Cancer Med2023
36920627Autolysis Affects the Iron Cargo of Ferritins in Neurons and Glial Cells at Different Rates in the Human Brain.Cell Mol Neurobiol2023
36917178Nucleolin promotes angiogenesis and endothelial metabolism along the oncofetal axis in the human brain vasculature.JCI Insight2023
36745526Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.Oncotarget2023
36831346CXCR3 Expression Is Associated with Advanced Tumor Stage and Grade Influencing Survival after Surgery of Localised Renal Cell Carcinoma.Cancers (Basel)2023
36900177Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma.Cancers (Basel)2023
36593030Minimally Invasive Cytopathology and Accurate Diagnosis: Technical Procedures and Ancillary Techniques.In Vivo2023
36287206Giant cell tumor of tendon sheath: A report of 216 cases.J Cutan Pathol2023
35020071BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study.Virchows Arch2022
35738637Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With <i>BCOR</i> Gene Alterations: A Case Report.In Vivo2022
35408777The Role of mTOR and eIF Signaling in Benign Endometrial Diseases.Int J Mol Sci2022
35674996"Dendroarchitectonics": From Santiago Ramón y Cajal to Enrique Ramón-Moliner or vice versa?Neurol Sci2022
35406783Unlaid Eggs: Ovarian Damage after Low-Dose Radiation.Cells2022
35725859Correction to: "Dendroarchitectonics": From Santiago Ramón y Cajal to Enrique Ramón⿿Moliner or vice versa?Neurol Sci2022
35574327A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.Front Oncol2022
35756933Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy.Front Neurol2022
35720265Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for <i>EGR2</i> in tumorigenesis.iScience2022
35718769Initiation and elongation factor co-expression correlates with recurrence and survival in epithelial ovarian cancer.J Ovarian Res2022
35717322Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.Mol Cancer2022
36816389The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells.Contemp Oncol (Pozn)2022
36097280Patient-derived head and neck tumor slice cultures: a versatile tool to study oncolytic virus action.Sci Rep2022
36088044LncRNA TUG1 promotes the migration and invasion in type I endometrial carcinoma cells by regulating E-N cadherin switch.Taiwan J Obstet Gynecol2022
35883472Relationship of micro-RNA, mRNA and eIF Expression in Tamoxifen-Adapted MCF-7 Breast Cancer Cells: Impact of miR-1972 on Gene Expression, Proliferation and Migration.Biomolecules2022
36387239The progress of protein synthesis factors eIFs, eEFs and eRFs in inflammatory bowel disease and colorectal cancer pathogenesis.Front Oncol2022
36189884Monitoring drug-target interactions through target engagement-mediated amplification on arrays and in situ.Nucleic Acids Res2022
36112544Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets.Clin Cancer Res2022
36005642The PROVIT Study-Effects of Multispecies Probiotic Add-on Treatment on Metabolomics in Major Depressive Disorder-A Randomized, Placebo-Controlled Trial.Metabolites2022
35159342The Translational Bridge between Inflammation and Hepatocarcinogenesis.Cells2022
35318125Kupffer cells are protective in alcoholic steatosis.Biochim Biophys Acta Mol Basis Dis2022
35220234Platelet to Lymphocyte Ratio Correlates With Carcinoma Progression in Pancreatic Intra Epithelial Neoplasia.Anticancer Res2022
34980502Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.Eur J Cancer2022
35089437A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection.Cell Mol Life Sci2022
35052653Nrf2 in the Field of Dentistry with Special Attention to NLRP3.Antioxidants (Basel)2022
32748971Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury.Hepatology2021
33602823Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.Proc Natl Acad Sci U S A2021
33546043Primary extranodal natural Killer/T-cell lymphoma in a child in the colon: A case report.Medicine (Baltimore)2021
  • 1 - 50 of 289

Recommended Authors

Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 3
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 1
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 2004
Number of shared co-authors 0
University of Udine
Career Start Year 2002
Number of shared co-authors 0
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 2
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Chengdu Medical College
Career Start Year 1999
Number of shared co-authors 0
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 1
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Wonju Severance Christian Hospital
Career Start Year 1993
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 3
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 0

Collaborators

Kepler University Hospital, Johannes Kepler University
Co-authored papers 17
Institute of Pathology, Medical University of Graz
Co-authored papers 14
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers 10
Medical University of Innsbruck
Co-authored papers 6
Medical University of Vienna
Co-authored papers 5
Karl Landsteiner University of Health Sciences
Co-authored papers 5
Lilly Research Laboratories
Co-authored papers 5
Medical University of Graz
Co-authored papers 5
Medical University Innsbruck
Co-authored papers 5
Medical University of Vienna
Co-authored papers 5
Medical University of Innsbruck
Co-authored papers 5
Medical University of Innsbruck
Co-authored papers 4
Medical University of Vienna
Co-authored papers 4
Karl Landsteiner University of Health Sciences
Co-authored papers 4
Diagnostic and Research Institute of Pathology, Medical University of Graz
Co-authored papers 4
Medical University of Vienna
Co-authored papers 4
Medical University of Vienna
Co-authored papers 4
Co-authored papers 4
Institute of Pathology, State Hospital Klagenfurt
Co-authored papers 4
Medical University of Innsbruck
Co-authored papers 4
Paracelsus Medical University Salzburg
Co-authored papers 3
Charite University Medicine Berlin
Co-authored papers 3
Medical University of Vienna
Co-authored papers 3
Karl Landsteiner University of Health Sciences
Co-authored papers 3
Kepler University Hospital
Co-authored papers 3
Medical University of Innsbruck
Co-authored papers 3
Max Planck Institute for Molecular Genetics
Co-authored papers 3
Medical University of Vienna
Co-authored papers 3
Medical University of Vienna
Co-authored papers 3
Johannes Kepler University
Co-authored papers 3